Bionomics is a productive drug discovery and development engine room focused on new treatments for cancer and serious disorders of the central nervous system (CNS). Through application of its proprietary technology platforms, MultiCore®, Angene® and ionX®, Bionomics has generated multiple drug candidates and targets in the therapeutic areas of Cancer, Anxiety, Multiple Sclerosis and Epilepsy. The company has a strong out-license record in conjunction with its in-house development program which has seen two highly promising drugs enter clinical trials in the past two years.
Company News /
by Rachael Jones -
6 years ago
04 Jan 2019 - The Australasian Gastro-Intestinal Trials Group is conducting a clinical trial with Bionomics (ASX:BNO) in combination with nivolumab.
Company News /
by Rachael Jones -
7 years ago
6 Apr 2018 -Global biopharmaceutical company Bionomics (ASX:BNO) today announced they will host Key Opinion Leader meetings focused on the treatment of post traumatic stress disord…
Company Presentations /
by Carolyn Herbert -
8 years ago
31 October 2016 - Bionomics Limited (ASX: BNO) CEO & Managing Director Dr Deborah Rathjen presents at the ASX Spotlight Series in Hong Kong.
Company News /
by Jessica Ellerm -
8 years ago
16 Sep 2016 - Bionomics Limited (ASX:BNO) announces it will present the results of its trials into an anti-anxiety drug treatment at an upcoming conference in Vienna.
Company News /
by -
9 years ago
08 Dec 2015 - Bionomics Limited (ASX:BNO) is set to launch Phase 2 of its novel anxiety drug BNC210.
Company News /
by -
9 years ago
04 Dec 2015 - Bionomics Limited (ASX:BNO) enters a trading halt at the request of the company.
Market Reports /
by -
10 years ago
02 Feb 2015 - ASX bounces on rate cut chatter. Incoming Westpac Banking Corporation (ASX:WBC) boss Brian Hartzer is stamping his authority on the bank at his first day in the job, …
Market Reports /
by -
10 years ago
02 Feb 2015 - Aus shares defy weak lead. Transurban Group Limited (ASX:TCL) has achieved financial close on the NorthConnex project in Sydney, New South Wales.
Company News /
by -
10 years ago
11 Nov 2014 - Bionomics Limited (ASX:BNO) to progress BNC210 to further clinical trials expecting to commence before the end of the year.
Resources Corner /
by -
10 years ago
10 Oct 2014 – There’s a raft of M&A activity this week - while a report examines the strength of the Sydney fintech sector and how it can be grown.
Market Reports /
by -
10 years ago
30 Sep 2014 - ASX set to slip amid HK protests. Shares in Bionomics Limited (ASX:BNO) rise after revealing new data from a trial of BNC105 in patients with metastatic renal cancer.
Resources Corner /
by -
10 years ago
19 Sep 2014 – The government has a disjointed set of grants and assistance packages for tech start-ups but calls are growing for the government to adopt lean startup techniques its…
Market Reports /
by -
10 years ago
05 Sep 2014 - Aus shares dip despite ECB stimulus. G8 Education Limited (ASX:GEM) settles the acquisition of 14 childcare and education centres in August.
Market Reports /
by -
10 years ago
24 Jun 2014 - Banks lead ASX lower despite gains in iron ore price overnight. Kathmandu Holdings Limited (ASX:KMD) the latest retailer to warn of a sales slump.
Market Reports /
by -
10 years ago
24 Jun 2014 - ASX dips lower after muted leads and despite a rise in the iron ore price overnight. David Jones Limited (ASX:DJS) edges closer to $2.2B takeover offer.
Market Reports /
by -
11 years ago
19 Mar 2014 - Aus shares flat despite Wall Street. Shares in Bionomics Limited (ASX:BNO) plunge over 27 per cent after it released results of Phase I trials of cancer drug.
Company Presentations /
by -
11 years ago
27 Feb 2014 - Bionomics Limited (ASX:BNO) CEO & Managing Director Deborah Rathjen presents at ASX Spotlight New York and London about the discovery and development of biopharmaceut…
Market Reports /
by -
12 years ago
17 Sep 2012 - Aus shares close 0.3% higher. Qantas Airways Limited’s (ASX:QAN) secures code share alliance with South African Airways for another two years.
Company News /
by -
12 years ago
19 Sep 2012 - Bionomics Limited (ASX:BNO) buys a US-based private biotechnology company called Eclipse Therapeutics Inc for $US10 million.
